Hongwei Liu

机构：Guangdong Medical College · ORCID：0000-0001-7779-5807

发表论文 9 篇 · 总被引 33 次 · h-index 3

代表论文

Astragalus polysaccharides inhibits tumor proliferation and enhances cisplatin sensitivity in bladder cancer by regulating the PI3K/AKT/FoxO1 axis (2025 · International Journal of Biological Macromolecules · 被引 16)
Research progress on PD-1 and PD-L1 inhibitors in the treatment of metastatic urothelial carcinoma (2023 · International Immunopharmacology · 被引 10)
CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway (2023 · Cell Cycle · 被引 7)
Genomic and AI-driven discovery in chronic prostatitis: Causal role of ITPR3 and therapeutic repurposing of raloxifene (2026 · European Journal of Pharmacology)
Development and validation of a risk prediction model for distant metastasis in muscle-invasive bladder cancer: a retrospective study integrating SEER data with external validation cohort and biomarker analysis (2025 · Frontiers in Oncology)
Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway (2025 · Molecular Carcinogenesis)